Lior Teitelbaum

Venture Investor at Johnson & Johnson

📍 United States🔄 Updated September 2026💼 6 investments📅 9 years investing🗓 Last invested Sep 2025
VC🌍 United StatesInvested this year
6
Total investments
1
Early stage
1
Mid stage
0
Late stage
9y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Sep 2025
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
Board Member
Dec 2024
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
Board Member
Feb 2024
A start-up developing novel ophthalmic therapeutics to treat major unmet needs for patients. PLEASE NOTE: Be aware of fake job listings on popular job posting websites that attempt to collect personal information from job applicants. Please note that Perceive Bio will only collect personal information using a legitimate company email domain, and will never offer payment or any financial transaction over text or email. Always verify that emails are directly from the company: from an @perceivebio.com email address. We will NOT ask you to purchase home office equipment or transfer other money as part of a hiring process. We will NOT contact you over Signal or WhatsApp as part of our recruiting process. We WILL ALWAYS meet with you in person (not over an electronic communication only) before hiring you.
Venture Investor JJDC, Inc.
Feb 2022
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
Board Member
Nov 2017
Tonomy has developed an innovative non-contact home tonometer and app, allowing individuals to self-measure their Intra-Ocular Pressure (IOP) at home. This advancement aims to reduce the risk and enhance the management of glaucoma. With Tonomy, users can receive a diagnosis to share with their physician, facilitating the creation of a treatment plan and, if necessary, obtaining a prescription—all from the comfort of their home.
Experience · 8 entries
All (8)
Investments (6)
Founder (1)
Board (5)
2025
Board Member
Sep 2025
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
2024
Board Member
Dec 2024
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
Board Member
Feb 2024
A start-up developing novel ophthalmic therapeutics to treat major unmet needs for patients. PLEASE NOTE: Be aware of fake job listings on popular job posting websites that attempt to collect personal information from job applicants. Please note that Perceive Bio will only collect personal information using a legitimate company email domain, and will never offer payment or any financial transaction over text or email. Always verify that emails are directly from the company: from an @perceivebio.com email address. We will NOT ask you to purchase home office equipment or transfer other money as part of a hiring process. We will NOT contact you over Signal or WhatsApp as part of our recruiting process. We WILL ALWAYS meet with you in person (not over an electronic communication only) before hiring you.
2022
Venture Investor JJDC, Inc.
Feb 2022
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
2017
Board Member
Nov 2017
Tonomy has developed an innovative non-contact home tonometer and app, allowing individuals to self-measure their Intra-Ocular Pressure (IOP) at home. This advancement aims to reduce the risk and enhance the management of glaucoma. With Tonomy, users can receive a diagnosis to share with their physician, facilitating the creation of a treatment plan and, if necessary, obtaining a prescription—all from the comfort of their home.
Show all 8 entries ↓
Investment activity
2017–2025 · 6 investments
20172202212024220251
Recent (last 2 years)Earlier